news roundup
Updated employee announcements, business news, awards, and recognition in the industry today.
Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand
Learn More |
Synteract, a CRO, has acquired KinderPharm, a pediatric CRO, focused on advancing pediatric drug development across all phases of clinical research. Together, Synteract and KinderPharm will deliver a single source model for preclinical and clinical development, along with the operational and logistical understanding required in working with children and their families.
Advertisement
The Potential for Disease-Modifying Therapies in Parkinson's Disease
On Demand
Learn More |
SAS' next-generation solutions for clinical trial data analysis and real world evidence debuted at PhUSE EU Connect in Frankfurt, Germany. This debut introduced SAS Life Science Analytics Framework and SAS Real World Evidence to help improve the development and safety of new pharmaceuticals with artificial intelligence.
MMS Holdings Inc., a data-focused CRO, announced that the company has assisted Korea-based Vivozon Inc. in achieving a Fast Track Designation from the Food and Drug Administration for VVZ-149, a non-opioid painkiller.
|
|